FDA Faces Explosion in Growth of Gene Therapies

The recent approval of Novartis s $2 million gene therapy Zolgensma, a one-shot cure that can prevent the death of infants from spinal muscular atrophy, reflects the emergence of a new world of effective treatments for critical conditions. Innovative therapies can replace, repair or inactivate aOriginal Article